Cargando…

CD133(+ )adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF)

BACKGROUND: CD133 is a cell surface marker of haematopoietic stem and progenitor cells. Leukaemia inhibitory factor (LIF), sustains proliferation and not differentiation of embryonic stem cells. We used CD133 to purify adult human retinal cells and aimed to determine what effect LIF had on these cul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carter, Debra A, Dick, Andrew D, Mayer, Eric J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649894/ https://www.ncbi.nlm.nih.gov/pubmed/19236693 http://dx.doi.org/10.1186/1471-2415-9-1

Ejemplares similares

Retinal blood vessel‐origin yes‐associated protein (YAP) governs astrocytic maturation via leukaemia inhibitory factor (LIF)
por: Ai, Li‐Qian‐Yu, et al.
Publicado: (2020)

COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF)
por: Metcalfe, Su M.
Publicado: (2020)

Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)
por: Rittchen, Sonja, et al.
Publicado: (2015)

Leukaemia Inhibitory Factor (LIF) Inhibits Cancer Stem Cells Tumorigenic Properties through Hippo Kinases Activation in Gastric Cancer
por: Seeneevassen, Lornella, et al.
Publicado: (2020)

CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy
por: Ke, Chien-Chih, et al.
Publicado: (2012)

Expression of leukemia inhibitory factor (LIF) and its receptor gp190 in human liver and in cultured human liver myofibroblasts. Cloning of new isoforms of LIF mRNA
por: Hisaka, Toru, et al.
Publicado: (2004)

Novel focused OCT-LIF endoscope
por: Wall, R. Andrew, et al.
Publicado: (2011)

Upregulation of Leukemia Inhibitory Factor (LIF) during the Early Stage of Optic Nerve Regeneration in Zebrafish
por: Ogai, Kazuhiro, et al.
Publicado: (2014)

The Role of the Leukemia Inhibitory Factor (LIF) — Pathway in Derivation and Maintenance of Murine Pluripotent Stem Cells
por: Graf, Urs, et al.
Publicado: (2011)

Production of biologically active recombinant buffalo leukemia inhibitory factor (BuLIF) in Escherichia Coli
por: Jamwal, Shradha, et al.
Publicado: (2022)

Allogeneic Embryos Disregulate Leukemia Inhibitory Factor (LIF) and Its Receptor in the Porcine Endometrium During Implantation
por: Cambra, Josep M., et al.
Publicado: (2020)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
por: Merlevede, Jane, et al.
Publicado: (2016)

Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF
por: Metcalfe, Su M., et al.
Publicado: (2015)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Leukemia Inhibitory Factor (LIF) Overexpression Increases the Angiogenic Potential of Bone Marrow Mesenchymal Stem/Stromal Cells
por: Santos, Girlaine Café, et al.
Publicado: (2020)

LIF-STAT signaling and trophoblast biology
por: Suman, Pankaj, et al.
Publicado: (2013)

Targeting LIF/LIFR signaling in cancer
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2021)

Beyond LIF Neurons on Neuromorphic Hardware
por: Ward, Mollie, et al.
Publicado: (2022)

The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa
por: Byrne, Ashleigh M., et al.
Publicado: (2016)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Leukemia Inhibitory Factor (LIF)-dependent, Pluripotent Stem Cells Established from Inner Cell Mass of Porcine Embryos
por: Telugu, Bhanu Prakash V. L., et al.
Publicado: (2011)

Comparison of the activity and pluripotency maintaining potential of human leukemia inhibitory factor (LIF) produced in E.coli and CHO cells
por: Haake, Claas, et al.
Publicado: (2011)

The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma
por: Humbert, Laure, et al.
Publicado: (2015)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Distinct and Conserved Prominin-1/CD133–Positive Retinal Cell Populations Identified across Species
por: Jászai, József, et al.
Publicado: (2011)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Reply: CD133 expression in different stages of gastric adenocarcinoma
por: Smith, L M, et al.
Publicado: (2009)

LIF-Dependent Signaling: New Pieces in the Lego
por: Mathieu, Marie-Emmanuelle, et al.
Publicado: (2011)

LIF signal in mouse embryonic stem cells
por: Ohtsuka, Satoshi, et al.
Publicado: (2015)

Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma
por: Zhang, Lin, et al.
Publicado: (2014)

A CD25(−) Positive Population of Activated B1 Cells Expresses LIFR and Responds to LIF
por: Tumang, Joseph R., et al.
Publicado: (2011)

LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?
por: Metcalfe, Su M
Publicado: (2020)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

CD133 in brain tumor: the prognostic factor
por: Li, Bin, et al.
Publicado: (2016)

CD133 Is a Marker of Bioenergetic Stress in Human Glioma
por: Griguer, Corinne E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_k8o9q0sr47up1jvtsciujdeit1